Sasaki Gen, Watanabe Yoshinobu, Miyamoto Wataru, Yasui Youichi, Morimoto Shota, Kawano Hirotaka
Department of Orthopaedic Surgery, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi, Tokyo, 173-8605, Japan.
Int Orthop. 2018 Jan;42(1):17-24. doi: 10.1007/s00264-017-3503-5. Epub 2017 May 24.
This study aimed to provide preliminary evidence regarding effectiveness of grafting beta-tricalcium phosphate (β-TCP) combined with a cancellous autograft for treating nonunion of long bones in the lower extremity due to infection by evaluating clinical and radiological outcomes.
We retrospectively reviewed the clinical and radiological results in seven patients (six men, one woman; median age 39 years) treated by the induced membrane technique for nonunion of the femur or tibia due to infection. In the second stage of the procedure, the bony defect was filled with a combination of autologous cancellous bone and β-TCP, which were mixed in approximately the same proportions. The time interval between the second stage of the procedure and bone healing was investigated. Radiographic characteristics including maximum bone gap and radiographic apparent bone gap were evaluated.
The median follow-up period was 14 months. Bone healing was achieved in a median of six months after the second procedure. The median maximum bone gap and radiographic apparent bone gap were 55 mm and 34 mm, respectively.
Use of β-TCP, which has osteoconductive ability, with an autograft provided good clinical and radiological outcomes. The findings of this preliminary study suggest the potential of β-TCP as a useful bone substitute for autografts in the induced membrane technique.
Our findings suggest that β-TCP may be an effective extender when using the induced membrane technique.
本研究旨在通过评估临床和放射学结果,为移植β-磷酸三钙(β-TCP)联合松质骨自体移植治疗下肢长骨感染性骨不连的有效性提供初步证据。
我们回顾性分析了7例因感染导致股骨或胫骨骨不连并接受诱导膜技术治疗的患者(6例男性,1例女性;中位年龄39岁)的临床和放射学结果。在手术的第二阶段,骨缺损用自体松质骨和β-TCP的混合物填充,二者比例大致相同。研究了手术第二阶段与骨愈合之间的时间间隔。评估了包括最大骨间隙和放射学表观骨间隙在内的放射学特征。
中位随访期为14个月。第二次手术后中位6个月实现骨愈合。中位最大骨间隙和放射学表观骨间隙分别为55毫米和34毫米。
具有骨传导能力的β-TCP与自体移植联合使用可带来良好的临床和放射学结果。这项初步研究的结果表明,β-TCP在诱导膜技术中作为自体移植的有用骨替代物具有潜力。
我们的研究结果表明,在使用诱导膜技术时,β-TCP可能是一种有效的填充物。